Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Vertex Hepatitis C Drug Wipes Out Virus For Toughest-to-Treat Patients Luke Timmerman 10/28/09 Boston
Vertex Selling Telaprevir Payment Rights Ryan McBride 07/10/09 Boston
Vertex Acquires Virochem for $375M to Make Cocktail Treatments For Hepatitis C Luke Timmerman 03/03/09 Boston
Out With Hedge Funds, In With Blue Bloods: Vertex Transforms Investor Base Via Stock Sale Luke Timmerman 02/20/09 Boston
Vertex Raises $320M in Secondary Stock Offering Luke Timmerman 02/19/09 Boston
Vertex CEO Josh Boger Retiring In May; Matthew Emmens To Fill Role Luke Timmerman 02/05/09 Boston
A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News Rebecca Zacks 11/05/08 Boston
Vertex Drug for Hepatitis C Shows Durable Virus-Killing Ability in Tough-to-Treat Patients Luke Timmerman 11/01/08 Boston
Vertex Gears up for Big Liver Disease Conference Luke Timmerman 10/29/08 Boston
Cocrystal Discovery Raises $10 Million To Make Pills Against Viral Infections Luke Timmerman 09/19/08 Seattle
Vertex Raises $191 Million in Stock Offering Luke Timmerman 09/18/08 Boston
Vertex To Sell 7 Million Shares of Stock Luke Timmerman 09/17/08 Boston
Vertex Fending Off Competitors By Treating the Toughest Patients With Hepatitis C Luke Timmerman 09/09/08 Boston
Vertex Drug Poised for Pivotal Trial Among Patients Who Fail Prior Hepatitis C Treatments Luke Timmerman 08/19/08 Boston
Vertex Marching Ahead With Cystic Fibrosis Program Luke Timmerman 08/01/08 Boston
Vertex’s Hepatitis C Drug Passes Test, Moving to Another Phase III Luke Timmerman 06/09/08 Boston
Vertex Jumps More Than 25 Percent on Hepatitis Drug Data Robert Buderi 03/31/08 Boston
Vertex Falls On Hepatitis Drug Delay Reports Robert Buderi 01/04/08 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.